Showing results (151-160 of 221) with videos related to
Sort By:
Pageof 23
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 10, 2006
Endonasal endoscopic resection of an ethmoidal solitary fibrous tumorP H Eloy, M C Nollevaux, J B Watelet, et al.Vaccine|December 4, 2013
Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analysesA T Newall, J F Reyes, J G Wood, et al.Vaccine|December 15, 2015
Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia criticalA T Newall, J F Reyes, P McIntyre, et al.Journal of Viral Hepatitis|August 26, 2010
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteersA De Schryver, K Verstrepen, L Vandersmissen, et al.Acta Gastro-Enterologica Belgica|August 6, 2014
Current and future health and economic impact of hepatitis C in BelgiumD Vandijck, C Moreno, P Stärkel, et al.European Journal of Neurology|November 20, 2009
The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALSP Van Damme, A Goris, V Race, et al.Acta Gastro-Enterologica Belgica|August 6, 2014
Hepatitis C epidemiology in BelgiumP Van Damme, W Laleman, P Stärkel, et al.Neuroscience|July 4, 2012
Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G⁹³A) miceK A Staats, M Van Rillaer, W Scheveneels, et al.Vaccine|September 15, 2018
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in AustraliaC Chen, P Beutels, J Wood, et al.Vaccine|April 9, 1999
The first combined vaccine against hepatitis A and B: an overviewS Thoelen, P Van Damme, A Leentvaar-Kuypers, et al.Pageof 23